DL-Ornithine Monohydrochloride

We are DL-Ornithine Monohydrochloride CAS:1069-31-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


DL-Ornithine Monohydrochloride
CAS RN: 1069-31-4
 

Solubility in water	Colorless & clear (c=5)
Loss on drying	Not more than 0.3%
Residue on ignition (as sulfate)	Not more than 0.1%
Sulfate (SO4)	Not more than 0.03%
Heavy metals (as Pb)	Not more than 10ppm
Iron (Fe)	Not more than 10ppm
Ammonium (NH4)	Not more than 0.02%
Arsenic (As2O3)	Not more than 1ppm
Other amino acids	Not detected by T.L.C.(The spotted amount, 10μg)
Assay	98.5%～101.0%

 




Related News: With the onset of the DMF system for APIs, the concentration of the API industry will further increase.2106-18-5 At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.(R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate CAS:149709-59-1 At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.isonicotinamide CAS:1453-82-3 The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.